1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
LAVA Medtech Acquisition Corp.

LAVA Medtech Acquisition Corp.

LVAC
LAVA Medtech Acquisition Corp.US flagNASDAQ Global Market
10.43
USD
- -
- -
149.93MMarket Cap
LAVA Medtech Acquisition Corp.
LVAC
(NASDAQ Global Market)

Recent

price

10.43

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
Monterey Capital Acquisition Corporation (MCAC)
North Atlantic Acquisition Corporation (NAACW)
Mijem Newcomm Tech Inc. (MJEM.CN)
Altitude Acquisition Corp. (ALTU)
FTAC Emerald Acquisition Corp. (EMLD)
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (SLACW)
Business
LAVA Medtech Acquisition Corp. LAVA Medtech Acquisition Corp. is a blank check company whose sole business activity is to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the healthcare and healthcare-related industries; it targets innovative, development- or early commercial-stage companies in medical devices, diagnostics, and digital health, mainly in the United States and Canada. Incorporated in 2021 and headquartered in Waltham, Massachusetts, the company operates as a subsidiary of LAVA Medtech Sponsor LP with no significant ongoing operations, products, or services beyond its acquisition mandate. In April 2023, LAVA Medtech Acquisition Corp. announced its liquidation and redemption of public shares at approximately $10.42 per share after failing to complete an initial business combination within the required timeframe, marking the cessation of its activities as a special purpose acquisition company.